Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03376256 · ClinicalTrials.gov registry record · NA
Compuflo Instrument for Thoracic ES Identification
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT03376256 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 2 participants.
The verdict
NCT03376256, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by the FDA for use in the procedure of the lumbar epidural, it is not used to perform the epidural procedure but rather to measure the epidural pressure. This study will likewise measure the epidural pressure.
Interventions
- DEVICE Compuflo Epidural Instrument
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2018-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03376256
The ClinicalTrials.gov registry entry for NCT03376256 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Compuflo Epidural Instrument is the first listed.
NCT03376256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03376256 about?
NCT03376256 is a clinical study titled "Compuflo Instrument for Thoracic ES Identification". The purpose of this pilot study is to evaluate whether the Compuflo Epidural Instrument injection pump technology, which is FDA approved for lumbar epidural anesthesia, is also capable of identifying the thoracic epidural space through measurement of pressure levels. While this device is approved by...
What is the current status of trial NCT03376256?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2018-07-11. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT03376256?
The interventions under investigation include: Compuflo Epidural Instrument (DEVICE).
Who is sponsoring clinical trial NCT03376256?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.